News

Filter

Current filters:

None

8110 to 8119 of 95956 results

Ipsen and Oncodesign collaborate on Parkinson's disease target

05-01-2012

French companies Oncodesign and Ipsen (Euronext: IPN) have entered into a research collaboration to discover…

IpsenLicensingNeurologicalOncodesignPharmaceuticalResearch

Lipitor and strategic collapse at Pfizer, a consultants view

05-01-2012

Now global pharma behemoth Pfizer (NYSE: PFE) spent $114 billion in 2000 for a hostile takeover of Warner-Lambert,…

Cardio-vascularFinancialLipitorMarkets & MarketingPfizerPharmaceutical

Vernalis jumps on deal with Genentech

05-01-2012

The UK's Vernalis (LSE: VER) saw its shares jump more than 5% to 20.75 yesterday, after the company revealed…

FinancialGenentechIpsenLicensingLundbeckPharmaceuticalRocheVernalis

Arena files complete response on lorcaserin

05-01-2012

In another attempt to gain approval for its obesity drug candidate that was turned down by US regulators…

Arena PharmaceuticalsEisailorcaserinLorquessMetabolicsNorth AmericaPharmaceuticalRegulationResearch

Strong results for Alkermes’ ALKS 5461 in major depressive disorder

04-01-2012

US drugmaker Alkermes (Nasdaq: ALKS) yesterday released positive early clinical results for a central…

AlkermesAripiprazoleNeurologicalPharmaceuticalResearch

Cornerstone acquires Cardiokine

04-01-2012

US specialty drugmaker Cornerstone Therapeutics (Nasdaq: CRTX) said yesterday that it has acquired Cardiokine,…

Cardio-vascularCardiokineCornerstone TherapeuticslixivaptanMergers & AcquisitionsMetabolicsPharmaceutical

FDA OKs generic Ritalin for Actavis and Mylan’s Keppra

04-01-2012

Iceland-based generic drugmaker Actavis says that it recently received approval from the US Food and…

ActavisGenericsKeppra XRMylan LaboratoriesNeurologicalRegulationRitalin LA

Many NIH-funded clinical trials go unpublished

04-01-2012

In a study that investigates the challenges of disseminating clinical research findings in peer-reviewed…

BiotechnologyPharmaceuticalResearch

Accelrys acquires VelQuest for $35 million

04-01-2012

Scientific enterprise R&D software and services company Accelrys (Nasdaq: ACCL) says that it has acquired…

AccelrysMergers & AcquisitionsPharmaceuticalResearchVelQuest

8110 to 8119 of 95956 results

Back to top